BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9450617)

  • 41. Differential regulation of preovulatory luteinizing hormone and follicle-stimulating hormone release by opioids in the proestrous rat.
    Kumru S; Simşek M; Yilmaz B; Sapmaz E; Kutlu S; Sandal S; Canpolat S
    Physiol Res; 2001; 50(4):397-403. PubMed ID: 11551146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of mu and kappa opioid receptor agonists and antagonists on contraction of isolated colon strips of rats with cathartic colon.
    Liu BH; Mo P; Zhang SB
    World J Gastroenterol; 2004 Jun; 10(11):1672-4. PubMed ID: 15162549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coactivation of μ- and κ-Opioid Receptors May Mediate the Protective Effect of Testosterone on the Development of Temporomandibular Joint Nociception in Male Rats.
    Macedo CG; Fanton LE; Fischer L; Tambeli CH
    J Oral Facial Pain Headache; 2016; 30(1):61-7. PubMed ID: 26817034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord.
    Tejwani GA; Sheu MJ; Sribanditmongkol P; Satyapriya A
    Brain Res; 1998 Jun; 797(2):305-12. PubMed ID: 9666154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Roles of different subtypes of opioid receptors in mediating the ventrolateral orbital cortex opioid-induced inhibition of mirror-neuropathic pain in the rat.
    Zhao M; Wang JY; Jia H; Tang JS
    Neuroscience; 2007 Feb; 144(4):1486-94. PubMed ID: 17184926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quinine-induced inhibition of gastrointestinal transit in mice: possible involvement of endogenous opioids.
    Santos FA; Rao VS
    Eur J Pharmacol; 1999 Jan; 364(2-3):193-7. PubMed ID: 9932723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
    Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
    Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of motility in isolated horse small intestine is mediated by κ but not µ opioid receptors.
    Menozzi A; Pozzoli C; Zullian C; Poli E; Serventi P; Bertini S
    Equine Vet J; 2012 May; 44(3):368-70. PubMed ID: 21883413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats.
    De Winter BY; Boeckxstaens GE; De Man JG; Moreels TG; Schuurkes JA; Peeters TL; Herman AG; Pelckmans PA
    Gut; 1999 Nov; 45(5):713-8. PubMed ID: 10517907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
    Tavani A; Petrillo P; La Regina A; Sbacchi M
    J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
    Alcaraz C; Vargas ML; Fuente T; Milanés MV
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.
    Schoffelmeer AN; Hogenboom F; Wardeh G; De Vries TJ
    Neuropharmacology; 2006 Sep; 51(4):773-81. PubMed ID: 16806307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of morphine, naloxone, and κ opioid manipulation on endocrine functioning and social behavior in monogamous titi monkeys (Callicebus cupreus).
    Ragen BJ; Maninger N; Mendoza SP; Bales KL
    Neuroscience; 2015 Feb; 287():32-42. PubMed ID: 25485481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of trigemino-hypoglossal reflex in rats by oxytocin is mediated by mu and kappa opioid receptors.
    Zubrzycka M; Fichna J; Janecka A
    Brain Res; 2005 Feb; 1035(1):67-72. PubMed ID: 15713278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ; Członkowski A; Lipkowski A; Herz A
    J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
    Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
    Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
    Stoller DC; Sim-Selley LJ; Smith FL
    Brain Res; 2007 Apr; 1142():28-36. PubMed ID: 17300766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
    Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
    Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
    Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.